-
Mashup Score: 5Fallout From COVID-19 Decline in Cancer Screening and Increase in Cancer-Related Deaths - The ASCO Post - 3 year(s) ago
Various studies at institutions in the United States and abroad have shown a substantial decline in cancer screening rates during the COVID-19 pandemic, suggesting that fewer cancers will be detected by screening and when they do manifest, they will be at more advanced stages. Indeed, cancer-related mortality rates have…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Anti-CD20 Monoclonal Antibodies and Risk of Severe COVID-19 Infection and Death in Patients With Lymphoma - The ASCO Post - 3 year(s) ago
Patients with lymphoma hospitalized for severe COVID-19 infection were at higher risk for prolonged hospital stay and death if they were treated with B-cell–depleting therapies (eg, rituximab, obinutuzumab) within the previous 12 months. The risk of persistent COVID-19 infection was also higher in people older than age…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Anti-CD20 Monoclonal Antibodies and Risk of Severe COVID-19 Infection and Death in Patients With Lymphoma https://t.co/mP4sZZgB8S #COVID19 #lymsm #hematology #AACRCovid
-
-
Mashup Score: 0
AACR Virtual Meeting: COVID-19 and Cancer 2021 David Fajgenbaum, MD, MBA, of the University of Pennsylvania, talks about his research efforts to find an already-approved drug that could treat his orphan disease—multicentric Castleman disease—and how that methodology may be applied to the coronavirus and the cytokine storm it can cause (Symposium 5). …
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
David Fajgenbaum, MD, MBA, on Repurposing Cancer Drugs to Treat COVID-19 https://t.co/Tqp4vfoCo9 #COVID19 #AACRCovid @AACR @DavidFajgenbaum @CureCastleman https://t.co/mKcrWzYZRn
-
-
Mashup Score: 1Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study - 3 year(s) ago
Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer status, baseline COVID-19 severity) was performed. Hydroxychloroquine with any other drug was associated with…
Source: Cancer DiscoveryCategories: Hem/Oncs, Latest HeadlinesTweet-
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera @peters_solange et al @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer n=2186
-
-
Mashup Score: 0
Giuseppe Curigliano, MD, PhD, of the University of Milan and Istituto Europeo Oncologico, talks about designing public health measures focused on COVID-19 morbidity and mortality for cancer patients, defining treatment and vaccine priorities, and creating a model to assess the impact of control measures (Symposium 6). Antoni Ribas, MD, PhD, on Highlights…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Giuseppe Curigliano, MD, PhD: In the Face of COVID, Continuity in Cancer Care https://t.co/27sA5CxFfx #COVID19 #cancer #AACRCovid @AACR @curijoey @LaStatale https://t.co/F5t62zHZUt
-
-
Mashup Score: 1Login | - 3 year(s) ago
This site uses cookies to function. Please accept use of cookies to proceed.This site uses cookies to function. Please accept use of cookies to proceed.
Source: ow.lyCategories: Hem/Oncs, Latest HeadlinesTweet-
Using Real-World Data (RWD) from an integrated platform for rapid analysis of patients with cancer +/- #COVID19 across distinct health systems [Jul 22, 2020] Gadgeel @HenryFordNews @mtmdphd @Aurora_Cancer et al. @Syapse #AACRCOVID #COVID19nCancer https://t.co/sXs1YgBGez
-
-
Mashup Score: 1
Antoni Ribas, MD, PhD, of the University of California, Los Angeles and Jonsson Comprehensive Cancer Center, and President of the American Association for Cancer Research, talks about why the meeting was held, how the coronavirus has affected cancer care and will impact long-term survivorship, as well as health-care disparities and changes to clinical trials. …
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Antoni Ribas, MD, PhD, on Highlights of AACR’s COVID-19 and Cancer Meeting https://t.co/KKhw9SMGo2 #COVID19 @AACR #AACRCovid @AACRPres @UCLAJCCC https://t.co/mETurXgarR
-
-
Mashup Score: 1Anti-CD20 Monoclonal Antibodies and Risk of Severe COVID-19 Infection and Death in Patients With Lymphoma - The ASCO Post - 3 year(s) ago
By Alice Goodman Posted: 3/2/2021 11:43:00 AM Last Updated: 3/2/2021 3:06:10 PM Patients with lymphoma hospitalized for severe COVID-19 infection were at higher risk for prolonged hospital stay and death if they were treated with B-cell–depleting therapies (eg, rituximab,…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Anti-CD20 Monoclonal Antibodies and Risk of Severe COVID-19 Infection and Death in Patients With Lymphoma https://t.co/CE8gSUC3wt #AACRCovid #COVID19 #lymsm
-
-
Mashup Score: 0Login | - 3 year(s) ago
This site uses cookies to function. Please accept use of cookies to proceed.This site uses cookies to function. Please accept use of cookies to proceed.
Source: ow.lyCategories: Hem/Oncs, Latest HeadlinesTweet-
Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) & other COVID consortiums {Paywall} - @brian_rini #AACRCovid SYMPOSIUM 12: EPIDEMIOLOGY & REGISTRIES OF #COVID19nCancer https://t.co/jzVZxpAmvu #AACRCovid #COVID19 #CCC19 @COVID19nCCC
-
-
Mashup Score: 0
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) in Rockville, Maryland, opened the AACR COVID-19 and Cancer …
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
#AACRCovid #COVID19nCANCER @YouTube Fauci - Coronavirus Infections: More Than Just The Common Cold https://t.co/0SK5NIxkoB @peters_solange Addressing New Vulnerabilities in Cancer at the Time of #COVID19 https://t.co/ca9GEUbsHK @trvrb Genomic Tracking https://t.co/29tk8aZlDz
-
Fallout From COVID-19: Decline in Cancer Screening and Increase in Cancer-Related Deaths https://t.co/3EijL519Hu #COVID19 #cancer #AACRCovid